Jula Inrig, Chief Medical Officer at Travere Therapeutics, Inc. (TVTX), sold 2,493 shares at $20.75 ($52K) on 2023-01-05, disclosed to the SEC on 2023-01-06.
Scheduled sale ($52k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.75 | 2,051 | $43K | 82.3% |
| 2 | $20.75 | 442 | $9K | 17.7% |
| Total | $20.75 avg | 2,493 | $52K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |